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ABSTRACT
Objective: The efficiency and speed of a system in identifying drug-related problems (DRPs) can support and optimize the performance of pharmacists. 
The objective of this research was to determine the time of analysis and the number of DRPs’ incidences identified by pharmacists with and without 
pharmacy support systems (PSS).
Methods: The present research was observational with cross-sectional design. The data collection was done prospectively in outpatients at hospital 
during January 2016. Observations were conducted to the difference between the analysis and the number of DRPs’ incidence identified by the 
pharmacists with and without the assistance of PSS. The research population was outpatient at a number of hospitals in Yogyakarta. The tools used 
in this research were PSS which were a clinical information system that can identify potential DRPs and included three main parts, namely, the 
patients’ profile, drug information, and analysis of DRPs. The identification result of DRPs was consisted of six DRPs categories, i.e., without treatment 
indication, treatment without indication, ineffective drug, too low dose, too high dose, and undesirable drug reactions.
Results: Pharmacists without PSS require faster time to analyze the prescription of outpatients. The time majority spent by pharmacists with PSS 
in reviewing the patients’ prescription lies in the length of time the patients enter the therapy-related data obtained manually by patients until the 
warning being displayed and making clinical decision related to the DRPs. The statistical test result using Goodness of fit test and Fisher between 
categories of DRPs incidences detected by pharmacists with and without the assistance of PPS indicates significant differences (p<0.05). Pharmacists 
with PSS can detect DRPs that are not detected by the pharmacist without PSS. DRPs mostly identified by pharmacists with the assistance of PSS are 
drug interactions and improper doses. Improper doses primarily identified in geriatric and pediatric patients’ prescription.
Conclusion: Pharmacists with PSS software can detect DRPs that are not detected by pharmacists only. However, pharmacists using the software PSS 
require a longer time in the identification of DRPs compared to pharmacists without using PSS.
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INTRODUCTION
Drug-related problems (DRPs) are events or circumstances related to 
drug therapy, which potentially or actually affect clinical outcomes of 
the patients. DRPs are capable of resulting significant morbidity and 
mortality and contribute to soaring health costs [1]. Several strategies 
have been done to prevent drug-related problems, for instance, the 
evaluation of drug treatment, education of health-care workers or 
patients, assessing treatment and participation of clinical pharmacists in 
health professional team. Daily activities in hospital characterized by a 
high number of patients, very limited time, and speed of services provide 
unlimited space for evaluating drug therapy [2]. Professional skills of 
pharmacists in identifying the DRPs cover knowledge not only regarding 
drug but also evidence-based guidelines and contemporary management 
of various medical conditions also play a role in the incidence of DRPs. 
Thereby, that the information technology in treatment management 
process has been suggested to improve appropriate and safe treatment. 
The utilization of computerized-based information technology is proven 
to efficiently assist the pharmacists in identifying potential DRPs [3-6].
Study center and consultation: Industry, management, and pharmacy 
services of Gadjah Mada University have developed software of clinical 
information system called Gama pharmacy support system (GPSS), 
in which this system is able to assess prescriptions in outpatient and 
provide warning on DRPs potential. GPSS is comprised three main 
parts, i.e., the patients’ profile, drug information, and DRPs analysis. The 
presence of such system is expected to assist pharmacists in making 
clinical decisions associated with patients’ treatment and to prevent 
DRPs incidences.
In the medical technology or intervention, a diagnostic test must be 
evaluated before being introduced into daily practice. Diagnostic 
accuracy plays a pivotal role in clinical evaluation [7]. The accuracy 
of a diagnostic test depends on the sensitivity and specificity. The 
computation result of GPSS diagnostic value has shown the sensitivity 
value of 97.2%, specificity of 45.2%, positive predictive value of 66.7%, 
and negative predictive value of 93.4%. The sensitivity value of 97.2% 
suggests that pharmacists with the assistance of GPSS are able to 
detect 95% of patients at risk of potential DRPs. The specificity value 
of 45.2% shows the capability of pharmacists with the help of GPSS 
to determine 45.2% of patients not at risk of potential DRPs. Previous 
research suggests that the safety warning system against drug use 
should have high sensitivity and specificity, provide clear information, 
not inhibit the workflow, and facilitate the handling upon warnings in 
safe and efficient manner [8]. However, there is no practical system 
that is able to achieve the sensitivity and specificity up to 100% [9]. 
The current system tends to have high sensitivity but generally low in 
specificity [10].
The efficiency and speed of a system in identifying DRPs can support 
and optimize the performance of pharmacists. Hatfield et al. (2014) 
reports that the implementation of computerized provider order entry 
system can allocate more time on clinical activities to strengthen clinical 
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services through monitoring in therapeutic regimens. The objective of 
this research was to determine the time of analysis and the number 
of DRPs incidences identified by pharmacists with and without GPSS 
assistance [11].
METHODS
The present research was observational with cross-sectional design. 
The data collection was done prospectively in outpatients at hospital 
during January 2016. Observations were conducted to the difference 
between the analysis and the number of DRPs incidence identified by 
the pharmacists with and without the assistance of GPSS.
The research population was patients attending outpatient treatment 
at a number of hospitals in Yogyakarta with patient inclusion criteria 
of pediatric, geriatric, and heart disorders. The patients that had 
met inclusion criteria are identified with the presence or absence 
of potential DRPs. Furthermore, measurement was undertaken for 
analysis time and total DRPs incidences.
The tools used in this research were GPSS which were a clinical 
information system that can identify potential DRPs and included 
three main parts, namely, the patients’ profile, drug information, and 
analysis of DRPs. The information data were consisted of drug’s name, 
indication, mechanism of actions, doses, drug interactions, side effects, 
and contraindications. The references employed for database creation 
of GPSS were Drug Information Handbook, National Formulary, Drug 
Interaction Facts, MIMS, and Beers Criteria (2012).
Drug analysis results were displayed in the form of warning, i.e., too 
big or too small; too frequent or less for the frequency; improper 
drug use in geriatric patients (Beers criteria); and drug interactions. 
The identification result of DRPs was classified according to Cipolle 
et al. (2004), consisted of six DRPs categories, i.e. without treatment 
indication, treatment without indication, ineffective drug, too low dose, 
too high dose, and undesirable drug reactions [12].
To determine whether differences existed in analysis time of DRPs by 
pharmacists with and without the assistance of GPSS, Mann–Whitney 
test was employed. Statistical test was done to determine whether 
there were significant differences in DRPs incidence number, and 
goodness of fit test was used. The statistical analysis was undertaken 
with a confidence level of 95%. Ethical Clearance was obtained from 
the medical faculty of Universitas Gadjah Mada Yogyakarta, Indonesia.
RESULTS AND DISCUSSION
In the development of health information technology, the validity and 
evaluation tests should be done beforehand to determine the ability of 
such system. GPSS is an electronic system supporting pharmaceutical 
clinical decision to detect potential DRPs which becomes one of the 
solutions to reduce, prevent, and resolve DRPs (Table 1).
GPSS validity tests has been carried out in pediatric, geriatric, and 
cardiovascular disorders. The results showed that the sensitivity of 
GPSS was 97.2% and specificity was 45.2%. Furthermore, an evaluation 
was done in this research on the analysis time and the type of DRPs 
detected by GPSS.
On any computer system, speed is a very crucial parameter for users’ 
acceptance in such system. Recommendation should appear exactly at 
the time of decision-making. When the application speed is slow, the 
users’ satisfaction decreases. Bates et al. (2003) reported that speed of 
information system is the most appreciated parameter by users as it 
should be a priority [13].
Table 2 implies that there are differences in analysis time of DRPs 
by pharmacists with and without GPSS. The time majority spent by 
pharmacists with GPSS in reviewing the patients’ recipe lies in the 
length of time the patients enter; the therapy-related data obtained 
manually by patients until the warning being displayed and making 
clinical decision related to the DRPs. Hoeks (2014) states that when 
a computerized system requires the user to enter data manually, the 
process uses a quite long time, especially in outpatient services, where 
the time is critical.
Pharmacists without GPSS require faster time to analyze the 
prescription of outpatients. The high number of patients and the 
need for fast service result in limited time for pharmacists to review 
the prescriptions. Blix (2007) reports that activity in hospitals is 
characterized by high number of patients, limited time, and requires 
the speed of service, which results in limited space to the pharmacists 
to evaluate the therapy [2]. Hatfield et al. (2014) conducts a 
research by comparing the time required by the pharmacists to 
conduct distribution, administrative and clinical activities, and 
other activities (personal time) using computerized physician order 
entry (CPOE) and without CPOE, showing the presence of significant 
differences. The pharmacists’ activities with CPOE require a longer 
time for clinical activity (>3 minutes). The long period is used to 
strengthen clinical services through monitoring of therapeutic 
regimens [11].
The research conducted by Fok and Lo (2002) is to assess the 
pharmacists’ workload in solving the problems related to recipes, 
including ambiguous, illegible, incomplete recipes, and to determine 
the problems and frequency of occurrence. Pharmacists use an average 
time of 20.1 minutes, starting from problem detection until the 
problems are resolved and the recipes are processed [14].
The number and types of DRPs
The difference of DRPs’ types detected by pharmacists with and without 
the assistance of GPSS can be seen in Table 3.
The statistical test result using goodness of fit test and Fisher between 
categories of DRPs’ incidences detected by pharmacists with and 
without the assistance of GPSS indicates significant differences 
(p<0.05). Pharmacists with the help of GPSS can detect DRPs that are 
not detected by the pharmacist without the help of GPSS. The research 
results by Verdoorn et al. (2015) show that the use of clinical decision 
support system (CDSS) for treatment review can identify DRPs with 












Number of drug prescribed
1-4 266 (66.8)
>4 132 (31.2)
Table 2: Differences between time analysis conducted DRPs 
pharmacists and pharmacists with GPSS





Time analysis of PSS group 300 110 (13-300) 0.000
Time analysis of pharmacist 
group
300 24 (4-196)
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higher numbers, but the level of implementation is low. It can be seen 
from the DRPs that can be resolved before and after the use of CDSS 
having similar number.
DRPs mostly identified by pharmacists with the assistance of GPSS 
are drug interactions and improper doses. Improper doses primarily 
identified in geriatric and pediatric patients’ prescription. The study by 
Tora et al. (2014) shows that the warning category for potential DRPs 
frequently identified by EES/CDSS in the age group >65 years old is 
drug-drug interaction with drug (38.6%), geriatric warning (30.8%), and 
duplications of therapy (25.6%). The geriatric warning includes warning 
in drug inaccuracies in the elderly (11% warning), extremely high doses 
(9%), and more than 3 types of psychotropic drug (3%) (Table 4) [4].
Drug interaction is warning generally appear at the most in patients 
with cardiovascular disorder. In moderate severity level, effects of 
between drug interactions have the potential to be life-threatening or 
capable of causing permanent damage. The largest drug interaction 
at moderate severity level is the interaction between bisoprolol and 
aspirin. The antihypertensive effects can be attenuated by aspirin 
through mechanisms of prostaglandin biosynthesis inhibition 
involved in activities hypertension activities. Meanwhile, the most 
common major interaction found is between clopidogrel and aspirin. 
The interaction effects can increase the risk of bleeding which can 
be life-threatening and may be higher in patients who are at high 
risk of transient ischemic attack or ischemic stroke [15]. Undesired 
effects because of drug interactions can be resolved by monitoring of 
clinic parameter, symptoms and signs of toxicity, doses adjustment, 
substituting drug with other alternative drugs, no longer administer one 
drug or preventing drug combination. The drug interactions appearing 
on GPSS are interaction mechanism, effects interaction, and interaction 
handling that could be used by pharmacists for the prevention of DRPs.
Incidence category of DRPs in geriatric and pediatric patient 
prescription at the most is improper doses. GPSS doses show a high 
sensitivity, but the specificity is rather low (79%). GPSS tends to be too 
quick and issue warnings related to doses; thus, it must be reviewed 
by a pharmacist by viewing information on GPSS and judging the 
condition of patients. Isaksen et al. (1999) conducted a validation of 
computer-based program to identify patients at high risk of DRPs 
using six criteria regarding the use of drug, i.e., by drug administration 
≥5 drugs, ≥12 doses per day, ≥4 changes of therapeutic regimens, with 
≥ chronic diseases, the history of noncompliance and drugs that require 
monitoring of drug level in the blood (therapeutic drug monitoring). 
The criteria for the number of daily doses have the highest sensitivity 
of 91.7%. It indicates that dose-related problems are highly sensitive to 
computerized analysis in the identification of DRPs in geriatric patients. 
Vulnerable populations, especially the pediatric and geriatric patients, 
are at risk of serious dosage errors, overdose in particular [16].
DRPs’ categories are related to incorrect dosage identified by GPSS 
including the doses and excessive or less drug frequency, improper drug 
use because of improper drug dose as it does not correspond to the 
geriatric based on Beers criteria. The incorrect dosage category shows a 
specificity of 79% and a positive predictive value of 15%. That is, GPSS is 
not able to detect geriatric patients actually have a dose-related DRPs. It is 
due to the PSS development system is only based on literature knowledge 
matched to the patients’ drug profile without entering patients’ profile 
data such as the general data of patients and clinical data of patients; 
thus, GPSS has not had the ability to search for daily dose recommended 
specifically for geriatric and pediatric. In addition, GPSS has not included 
guidelines for appropriate doses for patients with kidney disorders 
and drug doses should consider the laboratory data. Based on the few 
existing studies, GPSS development is still open to be conducted to 
determine the proper dose. Eppenga et al. (2012) conducted CDSS 
development including the determination of the drug dose that requires 
laboratory data and guidelines for the dose adjusted to kidney functions. 
The warning in this system includes interactions of drug-drug, drug-age, 
drug duplication, drug-disease, and dosage guidelines [17].
Based on the findings toward the review time of DRPs in prescription of 
outpatients treatment by the pharmacists with or without the support 
of GPSS, it shows that rapid analysis time does not guarantee the ability 
in detecting the presence of DRPs. The DRPs’ analysis using GPSS 
requires a longer time due to prescription’s data input process and 
requirement to read the warnings issued by GPSS. Warnings appearing 
in the GPSS should be revisited by the researchers as decision-makers 
in determining DRPs by means of reading the drug information found 
on GPSS and adapted to the patients’ clinical condition. Computer-
based access toward the drug completeness profile and warnings on 
potential problems recipe problems can reduce initial level of improper 
treatment [18].
CONCLUSION
GPSS can assist the pharmacists in identifying potential DRPs; 
nonetheless, the development of the tool is still required to enhance the 
specificity and sensitivity.
Table 3: The difference of DRPs types detected by pharmacists with and without the assistance of GPSS
DRPs N
Pharmacist+GPSS (%) Pharmacist (%)
Unnecessary drug needs additional drug therapy
Ineffective drug











GPSS: Gama pharmacy support system, DRPs: Drug-related problems
Table 4: Incidence category of DRPs in pediatric, geriatric, and cardiovascular disease patient prescription
DRPs N
Pediatric Geriatric Cardiovascular disease
Unnecessary drug needs additional drug therapy
Ineffective drug
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